*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Europe's Stoxx 600 index made gains for the seventh straight day on Wednesday amid a barrage of corporate earnings, after data pointed to stronger-than-expected GDP growth across the region.
London stocks extended their gains on Wednesday, after fresh data from the US showed a slowing in consumer price growth, alongside the country’s first economic contraction since 2022.
Analysts at Berenberg reiterated their 'buy' rating and 700. 0p target price on makeup business Warpaint London on Wednesday, stating it was confident in the group's outlook despite Q1 turbulence.
Swiss pharma giant Novartis announced on Wednesday that it is to buy American clinical-stage biopharma firm Regulus for up to $1. 7bn, bolstering its position in the renal disease treatment market.
Results and updates from a collection of blue chips were causing major moves on the FTSE 100 on Wednesday, with Smith & Nephew, GSK and Coca-Cola HBC rising strongly, and Glencore, Taylor Wimpey and Barclays suffering.
March's personal consumption expenditures price index pointed to a softening in inflationary pressures across the US, according to the Bureau of Economic Analysis, potentially giving the Federal Reserve room to move when it comes to monetary policy.
US companies eased up on hiring in April as they tried to prepare themselves for impacts stemming from Donald Trump's so-called "Liberation Day" tariffs, according to ADP.
America's economy contracted at an annualised rate of 0. 3% in the three months ended 31 March, according to a preliminary reading from the Bureau of Economic Analysis, the first decline since Q122 and a sharp reversal from the 2. 4% growth rate seen in Q4.
The FTSE 100 continued its march higher on Wednesday – marking its longest winning streak in more than eight years – though upside was limited on the back of gloomy data from China and cautiousness ahead of some crucial economic indicators and corporate earnings from the US.
Analysts at Canaccord Genuity raised their target price on online trading services Plus500 from 2,650. 0p to 2,764. 0p on Wednesday, stating that it expects to see "a bumper Q2" trading performance.
PureTech Health impressed the market with its annual results for 2024, as the company maintained a strong cash position while hitting a number of key clinical and regulatory milestones during the year.
Lexington Gold announced the signing of a drilling contract with Logan Drilling USA on Wednesday, to begin a new exploration campaign at its Jennings-Pioneer Project in South Carolina, targeting gold, silver, base metals and tellurium mineralisation.
Young’s Brewery reported strong trading for the year ended 31 March on Wednesday, with total managed revenue up 25. 4% and like-for-like sales rising 5. 7%, driven by continued investment in its premium pub and accommodation estate across London and the south of England.
